NGM - NGM Biopharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue108,66577,14185,589
Cost of Revenue95,71479,73682,105
Gross Profit12,951-2,5953,484
Operating Expenses
Research Development---
Selling General and Administrative17,26514,83011,845
Non Recurring---
Total Operating Expenses112,97994,56693,950
Operating Income or Loss-4,314-17,425-8,361
Income from Continuing Operations
Total Other Income/Expenses Net3,8212,2061,939
Earnings Before Interest and Taxes-4,314-17,425-8,361
Interest Expense---
Income Before Tax-493-15,219-6,422
Income Tax Expense--1,060500
Minority Interest---
Net Income From Continuing Ops-493-14,159-6,922
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-493-14,159-6,922
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-493-14,159-6,922